Page 38 - 385-67 สถาบันบำบัด P.10

Battjes, R. J., Gordon, M. S., O’Grady, K. E., Kinlock, T. W., & Carswell, M. A. (2003). Factors that
predict adolescent motivation for substance abuse treatment. Journal of substance
abuse treatment, 24(3), 221–232.
Camacho-Gomez, M., & Castellvi, P. (2020). Effectiveness of family intervention for
preventing relapse in first-episode psychosis until 24 months of follow-up: A
systematic review With meta-analysis of randomized controlled
trials. Schizophrenia bulletin, 46(1), 98–109.
https://doi.org/10.1093/schbul/sbz038
Chien, W. T., Cheung, E. F. C., Mui, J. H. C., Gray, R., & Ip, G. (2019). Adherence therapy for
schizophrenia: a randomised controlled trial. Hong Kong medical journal Xianggang
yi xue za zhi, 25 Suppl 2(1), 4–9.
Drake, R. E., O’Neal, E. L., & Wallach, M. A. (2008). A Systematic review of psychosocial research
on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of substance abuse treatment, 34(1), 123–138.
form https://doi.org/10.1016/j.jsat.2007.01.011
Emsley, R., Chiliza, B., Asmal, L., & Harvey, B. H. (2013). The nature of relapse in
schizophrenia. BMC psychiatry, 13, 50.
https://doi.org/10.1186/1471-244X-13-50
Retriveved August 19, 2022, form
Retriveved December 2, 2022, . Retriveved August 31, 2021,
Gumley, A. I., Bradstreet, S., Ainsworth, J., Allan, S., Alvarez-Jimenez, M., Aucott, L., Birchwood, M., Briggs, A., Bucci, S., Cotton, S. M., Engel, L., French, P., Lederman, R., Lewis, S., Machin, M., MacLennan, G., McLeod, H., McMeekin, N., Mihalopoulos, C., Morton, E., & Gleeson, J. (2022).
Retriveved October 1, 2022, form https://www.thelancet.com/pdfs/journals/lanpsy/PIIS2215-0366(22)00103-1.pdf.
Retriveved September 12, 2022, form
Retriveved December 1, 2022, from Liu, Y., Yang, X., Gillespie, A., Guo, Z., Ma, Y., Chen, R., & Li, Z. (2019).
Retriveved November 23, 2021 form
Harada, T., Tsutomi, H., Mori, R., & Wilson, D. B. (2018). Cognitive-behavioural treatment for
amphetamine-type stimulants (ATS)-use disorders. The Cochrane database of
systematic reviews, 12(12), CD011315
https://doi.org/10.1002/14651858.CD011315.pub2
Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018). Prevalence of
comorbid substance use in schizophrenia spectrum disorders in community and
clinical settings, 1990-2017: Systematic review and meta-analysis. Drug and alcohol
dependence, 191, 234–258.
https://doi.org/10.1016/j.drugalcdep.2018.07.011
prevention and positive symptom in first-episode schizophrenia using brief cognitive
behavioral therapy: A pilot randomized controlled study. Psychiatry research, 272,
275–283.
Targeting relapse
https://doi.org/10.1016/j.psychres.2018.12.130
36
The EMPOWER blended digital intervention for
relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial
in Scotland and Australia. The lancet. Psychiatry, 9(6), 477–486.